List of Tables
Table 1. Oral Hypoglycemic Medications Market Trends
Table 2. Oral Hypoglycemic Medications Market Drivers & Opportunity
Table 3. Oral Hypoglycemic Medications Market Challenges
Table 4. Oral Hypoglycemic Medications Market Restraints
Table 5. Global Oral Hypoglycemic Medications Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Oral Hypoglycemic Medications Revenue Market Share by Company (2019-2024)
Table 7. Global Oral Hypoglycemic Medications Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Oral Hypoglycemic Medications Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Oral Hypoglycemic Medications Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Oral Hypoglycemic Medications Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Oral Hypoglycemic Medications Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Oral Hypoglycemic Medications
Table 13. Global Oral Hypoglycemic Medications Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Hypoglycemic Medications as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Oral Hypoglycemic Medications Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Oral Hypoglycemic Medications Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Oral Hypoglycemic Medications Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Oral Hypoglycemic Medications Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Oral Hypoglycemic Medications Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Oral Hypoglycemic Medications Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Oral Hypoglycemic Medications Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Oral Hypoglycemic Medications Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Oral Hypoglycemic Medications Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Oral Hypoglycemic Medications Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Oral Hypoglycemic Medications Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Oral Hypoglycemic Medications Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Oral Hypoglycemic Medications Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Oral Hypoglycemic Medications Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Oral Hypoglycemic Medications Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Oral Hypoglycemic Medications Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Oral Hypoglycemic Medications Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Oral Hypoglycemic Medications Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Oral Hypoglycemic Medications Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Oral Hypoglycemic Medications Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Oral Hypoglycemic Medications Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Oral Hypoglycemic Medications Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Oral Hypoglycemic Medications Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Oral Hypoglycemic Medications Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Oral Hypoglycemic Medications Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Oral Hypoglycemic Medications Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Oral Hypoglycemic Medications Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Oral Hypoglycemic Medications Sales Value by Region (2019-2024) & (%)
Table 44. Global Oral Hypoglycemic Medications Sales Value by Region (2025-2030) & (%)
Table 45. Global Oral Hypoglycemic Medications Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Oral Hypoglycemic Medications Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Oral Hypoglycemic Medications Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Oral Hypoglycemic Medications Sales Volume by Region (2019-2024) & (%)
Table 49. Global Oral Hypoglycemic Medications Sales Volume by Region (2025-2030) & (%)
Table 50. Global Oral Hypoglycemic Medications Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Oral Hypoglycemic Medications Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Oral Hypoglycemic Medications Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Oral Hypoglycemic Medications Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Oral Hypoglycemic Medications Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Oral Hypoglycemic Medications Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Oral Hypoglycemic Medications Sales Volume, (2025-2030) & (K Units)
Table 57. Bayer Company Information
Table 58. Bayer Introduction and Business Overview
Table 59. Bayer Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Bayer Oral Hypoglycemic Medications Product Offerings
Table 61. Bayer Recent Development
Table 62. Merck Company Information
Table 63. Merck Introduction and Business Overview
Table 64. Merck Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Merck Oral Hypoglycemic Medications Product Offerings
Table 66. Merck Recent Development
Table 67. Novartis Company Information
Table 68. Novartis Introduction and Business Overview
Table 69. Novartis Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Novartis Oral Hypoglycemic Medications Product Offerings
Table 71. Novartis Recent Development
Table 72. Huadong Medicine Company Information
Table 73. Huadong Medicine Introduction and Business Overview
Table 74. Huadong Medicine Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Huadong Medicine Oral Hypoglycemic Medications Product Offerings
Table 76. Huadong Medicine Recent Development
Table 77. Sanofi Company Information
Table 78. Sanofi Introduction and Business Overview
Table 79. Sanofi Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Sanofi Oral Hypoglycemic Medications Product Offerings
Table 81. Sanofi Recent Development
Table 82. Novo Nordisk Company Information
Table 83. Novo Nordisk Introduction and Business Overview
Table 84. Novo Nordisk Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Novo Nordisk Oral Hypoglycemic Medications Product Offerings
Table 86. Novo Nordisk Recent Development
Table 87. Servier Company Information
Table 88. Servier Introduction and Business Overview
Table 89. Servier Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Servier Oral Hypoglycemic Medications Product Offerings
Table 91. Servier Recent Development
Table 92. Takeda Pharmaceutical Company Information
Table 93. Takeda Pharmaceutical Introduction and Business Overview
Table 94. Takeda Pharmaceutical Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Takeda Pharmaceutical Oral Hypoglycemic Medications Product Offerings
Table 96. Takeda Pharmaceutical Recent Development
Table 97. Luye Pharmaceutical Company Information
Table 98. Luye Pharmaceutical Introduction and Business Overview
Table 99. Luye Pharmaceutical Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. Luye Pharmaceutical Oral Hypoglycemic Medications Product Offerings
Table 101. Luye Pharmaceutical Recent Development
Table 102. Taiji Group Company Information
Table 103. Taiji Group Introduction and Business Overview
Table 104. Taiji Group Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Taiji Group Oral Hypoglycemic Medications Product Offerings
Table 106. Taiji Group Recent Development
Table 107. CR Double-Crane Company Information
Table 108. CR Double-Crane Introduction and Business Overview
Table 109. CR Double-Crane Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 110. CR Double-Crane Oral Hypoglycemic Medications Product Offerings
Table 111. CR Double-Crane Recent Development
Table 112. AstraZeneca Company Information
Table 113. AstraZeneca Introduction and Business Overview
Table 114. AstraZeneca Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 115. AstraZeneca Oral Hypoglycemic Medications Product Offerings
Table 116. AstraZeneca Recent Development
Table 117. Boehringer Ingelheim Company Information
Table 118. Boehringer Ingelheim Introduction and Business Overview
Table 119. Boehringer Ingelheim Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 120. Boehringer Ingelheim Oral Hypoglycemic Medications Product Offerings
Table 121. Boehringer Ingelheim Recent Development
Table 122. Qilu Pharmaceutical Company Information
Table 123. Qilu Pharmaceutical Introduction and Business Overview
Table 124. Qilu Pharmaceutical Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 125. Qilu Pharmaceutical Oral Hypoglycemic Medications Product Offerings
Table 126. Qilu Pharmaceutical Recent Development
Table 127. Jiangsu Deyuan Pharmaceutical Company Information
Table 128. Jiangsu Deyuan Pharmaceutical Introduction and Business Overview
Table 129. Jiangsu Deyuan Pharmaceutical Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 130. Jiangsu Deyuan Pharmaceutical Oral Hypoglycemic Medications Product Offerings
Table 131. Jiangsu Deyuan Pharmaceutical Recent Development
Table 132. CTTQ Company Information
Table 133. CTTQ Introduction and Business Overview
Table 134. CTTQ Oral Hypoglycemic Medications Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 135. CTTQ Oral Hypoglycemic Medications Product Offerings
Table 136. CTTQ Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Oral Hypoglycemic Medications Downstream Customers
Table 140. Oral Hypoglycemic Medications Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Oral Hypoglycemic Medications Product Picture
Figure 2. Global Oral Hypoglycemic Medications Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Oral Hypoglycemic Medications Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Oral Hypoglycemic Medications Sales Volume (2019-2030) & (K Units)
Figure 5. Global Oral Hypoglycemic Medications Sales Price (2019-2030) & (US$/Unit)
Figure 6. Oral Hypoglycemic Medications Report Years Considered
Figure 7. Global Oral Hypoglycemic Medications Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Oral Hypoglycemic Medications Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Oral Hypoglycemic Medications Revenue in 2023
Figure 10. Oral Hypoglycemic Medications Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Biguanides Picture
Figure 12. Sulfonylureas Picture
Figure 13. Meglitinides Picture
Figure 14. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Picture
Figure 15. SGLT2 Inhibitors Picture
Figure 16. Thiazolidinediones Picture
Figure 17. Alpha-Glucosidase Inhibitors Picture
Figure 18. Other Picture
Figure 19. Global Oral Hypoglycemic Medications Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Oral Hypoglycemic Medications Sales Value Market Share by Type, 2023 & 2030
Figure 21. Global Oral Hypoglycemic Medications Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 22. Global Oral Hypoglycemic Medications Sales Volume Market Share by Type, 2023 & 2030
Figure 23. Global Oral Hypoglycemic Medications Price by Type (2019-2030) & (US$/Unit)
Figure 24. Product Picture of Hospital
Figure 25. Product Picture of Clinic
Figure 26. Product Picture of Other
Figure 27. Global Oral Hypoglycemic Medications Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 28. Global Oral Hypoglycemic Medications Sales Value Market Share by Application, 2023 & 2030
Figure 29. Global Oral Hypoglycemic Medications Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 30. Global Oral Hypoglycemic Medications Sales Volume Market Share by Application, 2023 & 2030
Figure 31. Global Oral Hypoglycemic Medications Price by Application (2019-2030) & (US$/Unit)
Figure 32. North America Oral Hypoglycemic Medications Sales Value (2019-2030) & (US$ Million)
Figure 33. North America Oral Hypoglycemic Medications Sales Value by Country (%), 2023 VS 2030
Figure 34. Europe Oral Hypoglycemic Medications Sales Value (2019-2030) & (US$ Million)
Figure 35. Europe Oral Hypoglycemic Medications Sales Value by Country (%), 2023 VS 2030
Figure 36. Asia Pacific Oral Hypoglycemic Medications Sales Value (2019-2030) & (US$ Million)
Figure 37. Asia Pacific Oral Hypoglycemic Medications Sales Value by Country (%), 2023 VS 2030
Figure 38. South America Oral Hypoglycemic Medications Sales Value (2019-2030) & (US$ Million)
Figure 39. South America Oral Hypoglycemic Medications Sales Value by Country (%), 2023 VS 2030
Figure 40. Middle East & Africa Oral Hypoglycemic Medications Sales Value (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Oral Hypoglycemic Medications Sales Value by Country (%), 2023 VS 2030
Figure 42. Key Countries/Regions Oral Hypoglycemic Medications Sales Value (%), (2019-2030)
Figure 43. Key Countries/Regions Oral Hypoglycemic Medications Sales Volume (%), (2019-2030)
Figure 44. United States Oral Hypoglycemic Medications Sales Value, (2019-2030) & (US$ Million)
Figure 45. United States Oral Hypoglycemic Medications Sales Value by Type (%), 2023 VS 2030
Figure 46. United States Oral Hypoglycemic Medications Sales Value by Application (%), 2023 VS 2030
Figure 47. Europe Oral Hypoglycemic Medications Sales Value, (2019-2030) & (US$ Million)
Figure 48. Europe Oral Hypoglycemic Medications Sales Value by Type (%), 2023 VS 2030
Figure 49. Europe Oral Hypoglycemic Medications Sales Value by Application (%), 2023 VS 2030
Figure 50. China Oral Hypoglycemic Medications Sales Value, (2019-2030) & (US$ Million)
Figure 51. China Oral Hypoglycemic Medications Sales Value by Type (%), 2023 VS 2030
Figure 52. China Oral Hypoglycemic Medications Sales Value by Application (%), 2023 VS 2030
Figure 53. Japan Oral Hypoglycemic Medications Sales Value, (2019-2030) & (US$ Million)
Figure 54. Japan Oral Hypoglycemic Medications Sales Value by Type (%), 2023 VS 2030
Figure 55. Japan Oral Hypoglycemic Medications Sales Value by Application (%), 2023 VS 2030
Figure 56. South Korea Oral Hypoglycemic Medications Sales Value, (2019-2030) & (US$ Million)
Figure 57. South Korea Oral Hypoglycemic Medications Sales Value by Type (%), 2023 VS 2030
Figure 58. South Korea Oral Hypoglycemic Medications Sales Value by Application (%), 2023 VS 2030
Figure 59. Southeast Asia Oral Hypoglycemic Medications Sales Value, (2019-2030) & (US$ Million)
Figure 60. Southeast Asia Oral Hypoglycemic Medications Sales Value by Type (%), 2023 VS 2030
Figure 61. Southeast Asia Oral Hypoglycemic Medications Sales Value by Application (%), 2023 VS 2030
Figure 62. India Oral Hypoglycemic Medications Sales Value, (2019-2030) & (US$ Million)
Figure 63. India Oral Hypoglycemic Medications Sales Value by Type (%), 2023 VS 2030
Figure 64. India Oral Hypoglycemic Medications Sales Value by Application (%), 2023 VS 2030
Figure 65. Oral Hypoglycemic Medications Industrial Chain
Figure 66. Oral Hypoglycemic Medications Manufacturing Cost Structure
Figure 67. Channels of Distribution (Direct Sales, and Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
